Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities

This publication has 19 references indexed in Scilit:

• Anal Carcinomas in HIV-Positive Patients: High-Dose Chemoradiotherapy Is Feasible in the Era of Highly Active Antiretroviral Therapy
  Diseases of the Colon & Rectum, 2005
• Increased Incidence of Squamous Cell Anal Cancer Among Men With AIDS in the Era of Highly Active Antiretroviral Therapy
  Sexually Transmitted Diseases, 2005
• Outcome of HIV-Infected Patients With Invasive Squamous-Cell Carcinoma of the Anal Canal in the Era of Highly Active Antiretroviral Therapy
  Diseases of the Colon & Rectum, 2004
• HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients
  Diseases of the Colon & Rectum, 2001
• Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
  JNCI Journal of the National Cancer Institute, 2000
• Treatment of HIV-associated invasive anal cancer with combined chemoradiation
  European Journal Of Cancer, 2000
• The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Low Acute Toxicity of Radiotherapy and Radiochemotherapy in Patients with Cancer of the Anal Canal and HIV-infection
  Acta Oncologica, 1997
• Results of combined modality therapy for patients with anal cancer (E7283). An eastern cooperative oncology group study
  Cancer, 1995